A61K 47/6905
The form being a colloid or an emulsion
Official title: {the form being a colloid or an emulsion}
A61K47/6905 (The form being a colloid or an emulsion) appears on 1,412 US grants and 2,504 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,412
- Published applications
- 2,504
- Assignees
- 1,049
- Inventors
- 4,780
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 3 | 0 |
| 1989 | 6 | 0 |
| 1990 | 0 | 0 |
| 1991 | 7 | 0 |
| 1992 | 6 | 0 |
| 1993 | 8 | 0 |
| 1994 | 7 | 0 |
| 1995 | 4 | 0 |
| 1996 | 14 | 0 |
| 1997 | 11 | 0 |
| 1998 | 19 | 0 |
| 1999 | 24 | 0 |
| 2000 | 24 | 0 |
| 2001 | 16 | 4 |
| 2002 | 18 | 32 |
| 2003 | 16 | 45 |
| 2004 | 10 | 34 |
| 2005 | 11 | 54 |
| 2006 | 17 | 39 |
| 2007 | 14 | 45 |
| 2008 | 16 | 60 |
| 2009 | 15 | 55 |
| 2010 | 24 | 98 |
| 2011 | 23 | 89 |
| 2012 | 49 | 77 |
| 2013 | 51 | 118 |
| 2014 | 60 | 106 |
| 2015 | 61 | 93 |
| 2016 | 71 | 111 |
| 2017 | 76 | 116 |
| 2018 | 72 | 132 |
| 2019 | 81 | 146 |
| 2020 | 80 | 154 |
| 2021 | 80 | 161 |
| 2022 | 84 | 175 |
| 2023 | 82 | 149 |
| 2024 | 87 | 151 |
| 2025 | 94 | 155 |
| 2026 | 70 | 105 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Drug containing targeting liposomes6 Oct 2026US 12,752,016 B2Nextage Therapeutics Ltd.
- Methods of loading extracellular vesicles29 Sep 2026US 12,746,291 B2Lonza Sales AG
- Methods of producing microbubble drug conjugates, viral gene therapy microbubble conjugates and targeted microbubbles29 Sep 2026US 12,746,292 B2
- Neutrophil elastase binding peptides and compositions thereof29 Sep 2026US 12,747,280 B2Case Western Reserve University
- Compositions comprising HDAC inhibitors and retinoids22 Sep 2026US 12,740,953 B2The Regents of the University of California
- Nanoparticles for photoimmune therapy comprising photosensitizer and adjuvant, and usage thereof8 Oct 2026US 2026/0306632 A1Korea Institute of Science and Technology
- Liposome conjugate targeting m2 macrophage and use thereof8 Oct 2026US 2026/0306657 A1Hangzhou Normal University
- Methods of sensitizing tumors to treatment with immune checkpoint inhibitors8 Oct 2026US 2026/0306658 A1University of Florida Research Foundation, Inc.
- Lipid nanoparticles and methods of manufacture and use thereof8 Oct 2026US 2026/0306659 A1Ablynx N. V.
- Targeted lipid nanoparticles for treating central nervous system injuries8 Oct 2026US 2026/0306665 A1Wisconsin Alumni Research Foundation
Most cited
By later US patents
- Liposomes with enhanced circulation time1,198US 5,013,556 ALiposome Technology, Inc. · 1991
- Therapeutic delivery systems related applications384US 5,542,935 AImaR.sub.x Pharmaceutical Corp. · 1996
- Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer378US 5,976,567 AInex Pharmaceuticals Corporation · 1999
- Lipid formulation340US 8,158,601 B2Alnylam Pharmaceuticals, Inc. · 2012
- Microreservoir liposome composition and method314US 5,225,212 ALiposome Technology, Inc. · 1993